• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Deals
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Multi-service
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • News & insights
  • Events
  • Conferences
  • Pharma Forum 2023: P…
Pharma Forum Patents Special

Pharma Forum 2023: Patents Special

Industry event
3 October 2023
14:00 - 18:00 BST
Click here to register
Share this event
  • Share this event

Pharma Forum is back and this year our flagship event has a special focus on patents. Join us at the Royal College of Physicians for an afternoon exploring the most recent as well as future legal changes to patent issues faced by pharmaceuticals and biologics companies operating in the UK and EU. 

Register here

2023 marks a significant year for patents holders following the long-anticipated opening of the Unified Patent Court (UPC) in June. With this, our leading international Patents team will present a thorough update on the first three months since the court launched, looking at the patterns we've seen emerge to date and what implications this will have for patent litigation in the UK and EU.

We'll also provide an update on the EU pharmaceutical legislation reform, highlighting the key considerations pharmaceuticals and biologics companies need to know.

Following a busy afternoon of presentations and panels, we'll be hosting drinks from 5:45pm.
See the agenda below.

Expertise

Sectors

Life sciences & healthcare
Digital health
Pharmaceuticals

Agenda

14:00 – Registration

14:30 – Welcome

14:45 – UPC: the first three months

  • Emerging patterns
  • Implications for the UK and EU

15:40 – Break

16:00 – EU pharma package reform

  • SPC reform
  • Bolar exemption
  • Compulsory licensing changes
  • Data exclusivity and orphan drug exclusivity

17:15 – Plausibility

17:45 – Closing remarks

18:00 – Drinks and networking

Our speakers

Amanda Ebbutt

Amanda Ebbutt

Partner

London
+44 20 7300 7130
Email me
View profile
Paul England

Dr Paul England

Senior Counsel – Knowledge

London
+44 20 7300 7000
Email me
View profile

Register for this event

Click here to register

If you have any questions please use the following details:

Email us

Related events

A view of space and the earth as symbol for the spaceship industry

Defence Technology Exploration Programme Finale

Location In Person
9 December, 14:30 - 18:30 GMT
Guest speakers Edward Ebbern
Colour pencils

Getty Images v Stability AI: what can we learn about the use of trademarks in AI outputs?

Online Online
11 December, 14:00 - 15:00 GMT
Speakers Louise Popple

FinReg Plus

Location In Person
15 January, 08:30 - 10:00 GMT
Speakers Martin Dowdall & Clare Reynolds & Others
See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing